Patents by Inventor Jean-Noel Billaud

Jean-Noel Billaud has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HEPATITIS VIRUS CORE PROTEINS AS VACCINE PLATFORMS AND METHODS OF USE THEREOF
    Publication number: 20110206724
    Abstract: The present invention relates to hepatitis virus core proteins and nucleic acids. In particular, the present invention provides compositions and methods comprising recombinant hepatitis virus core proteins or nucleic acids for use in vaccine formulations.
    Type: Application
    Filed: December 23, 2010
    Publication date: August 25, 2011
    Applicant: Vaccine Research Institute of San Diego
    Inventors: David R. MILICH, Jean-Noel Billaud
  • Hepatitis virus core proteins as vaccine platforms and methods of use thereof
    Patent number: 7883843
    Abstract: The present invention relates to hepatitis virus core proteins and nucleic acids. In particular, the present invention provides compositions and methods comprising recombinant hepatitis virus core proteins or nucleic acids for use in vaccine formulations.
    Type: Grant
    Filed: July 19, 2004
    Date of Patent: February 8, 2011
    Assignee: Vaccine Research Institute of San Diego
    Inventors: David R. Milich, Jean-Noel Billaud
  • Rodent hepatitis B virus core proteins as vaccine platforms and methods of use thereof
    Patent number: 7811576
    Abstract: The present invention relates to hepatitis virus core proteins and nucleic acids. In particular, the present invention provides compositions and methods comprising recombinant hepatitis virus core proteins or nucleic acids for use in vaccine formulations.
    Type: Grant
    Filed: January 7, 2008
    Date of Patent: October 12, 2010
    Assignee: Vaccine Research Institute of San Diego
    Inventors: David R. Milich, Jean-Noel Billaud
  • Rodent hepatitis B virus core proteins as vaccine platforms and methods of thereof
    Publication number: 20080220009
    Abstract: The present invention relates to hepatitis virus core proteins and nucleic acids. In particular, the present invention provides compositions and methods comprising recombinant hepatitis virus core proteins or nucleic acids for use in vaccine formulations.
    Type: Application
    Filed: January 7, 2008
    Publication date: September 11, 2008
    Applicant: Vaccine Research Institute of San Diego
    Inventors: David R. Milich, Jean-Noel Billaud
  • Hepadna virus core proteins as vaccine platforms and methods of use thereof
    Publication number: 20080138892
    Abstract: The present invention relates to hepatitis virus core proteins and nucleic acids. In particular, the present invention provides compositions and methods comprising recombinant hepatitis virus core proteins or nucleic acids for use in vaccine formulations.
    Type: Application
    Filed: December 5, 2006
    Publication date: June 12, 2008
    Applicant: Vaccine Research Institute of San Diego
    Inventors: David R. Milich, Jean-Noel Billaud
  • Hepatitis Virus Core Proteins as Vaccine Platforms and Methods of Use Thereof
    Publication number: 20080131452
    Abstract: The present invention relates to hepatitis virus core proteins and nucleic acids. In particular, the present invention provides compositions and methods comprising recombinant hepatitis virus core proteins or nucleic acids for use in vaccine formulations.
    Type: Application
    Filed: July 19, 2004
    Publication date: June 5, 2008
    Applicant: VACCINE RESEARCH INSTITUTE OF SAN DIEGO
    Inventors: David R. Milich, Jean-Noel Billaud
  • Rodent hepatitis B virus core proteins as vaccine platforms and methods of use thereof
    Patent number: 7320795
    Abstract: The present invention relates to hepatitis virus core proteins and nucleic acids. In particular, the present invention provides compositions and methods comprising recombinant hepatitis virus core proteins or nucleic acids for use in vaccine formulations.
    Type: Grant
    Filed: July 30, 2003
    Date of Patent: January 22, 2008
    Assignee: Vaccine Research Institute of San Diego
    Inventors: David R. Milich, Jean-Noel Billaud
  • Human hepatitis B virus core proteins as vaccine platforms and methods of use thereof
    Patent number: 7144712
    Abstract: The present invention relates to hepatitis virus core proteins and nucleic acids. In particular, the present invention provides compositions and methods comprising recombinant hepatitis virus core proteins or nucleic acids for use in vaccine formulations.
    Type: Grant
    Filed: July 30, 2003
    Date of Patent: December 5, 2006
    Assignee: Vaccine Research Institute of San Diego
    Inventors: David R. Milich, Jean-Noel Billaud
  • Human hepatitis B virus core proteins as vaccine platforms and methods of use thereof
    Publication number: 20050025782
    Abstract: The present invention relates to hepatitis virus core proteins and nucleic acids. In particular, the present invention provides compositions and methods comprising recombinant hepatitis virus core proteins or nucleic acids for use in vaccine formulations.
    Type: Application
    Filed: July 30, 2003
    Publication date: February 3, 2005
    Applicant: Vaccine Research Institute of San Diego
    Inventors: David Milich, Jean-Noel Billaud
  • Rodent hepatitis B virus core proteins as vaccine platforms and methods of use thereof
    Publication number: 20050025781
    Abstract: The present invention relates to hepatitis virus core proteins and nucleic acids. In particular, the present invention provides compositions and methods comprising recombinant hepatitis virus core proteins or nucleic acids for use in vaccine formulations.
    Type: Application
    Filed: July 30, 2003
    Publication date: February 3, 2005
    Inventors: David Milich, Jean-Noel Billaud